Tag: Hatch-Waxman Act
Recent Patent Cases and Generic Delays: 2023-2025 Examples
Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years due to patent litigation. Learn how patent thickets, the 30-month stay, and legal tactics are blocking affordable medicines for patients.